Chronic hypoxic pulmonary hypertension is an important clinical disorder causing significant morbidity. Despite recent discoveries, many molecular mechanisms involved in its pathogenesis remain unexplored. We have undertaken a systematic and unbiased approach to gain global insights into this complex process. By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we identified the dominant temporal patterns of gene expression during progression and regression of hypoxic pulmonary hypertension. We next integrated these results with global gene annotation analysis to identify key biological themes involved in the development and resolution of hypoxic pulmonary hypertension and vascular remodeling. This novel approach assigned biological roles to thousands of candidate genes based on their temporal expression profiles and membership in specific biological modules. Our procedure confirmed several molecular pathways and gene products known to be important in hypoxic pulmonary hypertension. Furthermore, we discovered several novel candidates and molecular mechanisms including IQGAP1, decorin, IGFBP3, and lactotransferrin that may play crucial roles in hypoxic pulmonary hypertension and vascular remodeling. Our methodology of integrating transcriptional profiling, cluster analysis and global gene annotation provides new insights into the pathophysiology of pulmonary hypertension and is applicable to other models of human disease.
Introduction
Chronic pulmonary arterial hypertension is a common clinical disorder causing significant morbidity and mortality (31) . Chronic pulmonary hypertension has several different etiologies, but hypoxic pulmonary vasoconstriction is the primary mechanism in the development of pulmonary hypertension associated with sleep apnea, chronic obstructive pulmonary disease and mountain sickness. Chronic elevation of pulmonary arterial pressure due to hypoxia induces profound remodeling of the vasculature (37) . The media thickens due to hypertrophy and proliferation of smooth muscle cells, and proliferation of fibroblasts in the adventitia.
Extracellular matrix (ECM) remodeling with increased deposition of elastin and collagens, and activation of matrix metalloproteinases and growth factors are other hallmarks of this process.
Although the histopathological changes seen in pulmonary arterioles during chronic hypoxia are less severe than those seen in primary pulmonary hypertension, hypoxic pulmonary hypertension is a much more common clinical entity (31) .
In recent years, several important regulators and molecular pathways in the development of pulmonary vascular remodeling due to chronic hypoxia have been identified. They fall into diverse functional groups, including transcription factors (hypoxia inducible factor-1), vasoactive molecules (prostacyclin, endothelin-1, nitric oxide), growth factors (transforming growth factor-β, vascular endothelial growth factor), and ECM components (matrix metalloproteinases, tenascin C) (21) . The literature on genes involved in regression of pulmonary hypertension and vascular remodeling is more limited, although the expression patterns of several ECM-degrading genes during regression of pulmonary vascular remodeling in a rat model of hypoxic pulmonary hypertension have been reported (40) . Despite important advances in elucidating the molecular mechanisms of hypoxic pulmonary hypertension and vascular remodeling, we believe that only a subset of the critical genes participating in this process has been identified to date.
The present study was designed to undertake a systematic search for novel genes and mechanisms involved in progression and regression of pulmonary hypertension and vascular remodeling in a murine model of hypoxia-induced chronic pulmonary hypertension. We utilized global expression profiling during induction and resolution of hypoxic pulmonary hypertension to obtain complex temporal patterns of gene expression and systematically narrowed candidate gene lists using rigorous statistical criteria and classification algorithms. We independently confirmed differential gene expression using quantitative real time RT-PCR for several candidates and protein level for one candidate gene. By statistically linking thousands of differentially expressed genes to gene annotation databases we obtained a global view of the key biological processes in hypoxic pulmonary hypertension. Integration of cluster analysis with gene annotation enabled us to identify several novel pathways and candidate genes that may be involved in development and regression of pulmonary hypertension.
Materials and Methods

Experiment Design
Ninety, 8 week old, male Balb/C mice (Jackson Laboratory) were randomized to experimental and control groups ( Figure 1 ). All mice were housed in the same specific pathogen free environment. The experimental group was placed in a hypobaric chamber and exposed to 0.5 atmosphere (inspired partial pressure of oxygen, P i O 2 = 75 torr) for 21 days and then returned to sea level (P i O 2 = 150 torr) for an additional 14 days. Control mice were housed at sea level for the entire duration of experiment (35 days). On days 1, 3, 7, 14 and 21 five mice from each group were anesthetized with intraperitoneal injection of ketamine (70 mg/kg) and xylazine (10 mg/kg) and sacrificed by exsanguination in accordance with our institutional animal guidelines.
The pulmonary arteries were flushed with 30 cc of RNase-free PBS solution, whole lungs were then removed, immediately frozen in liquid nitrogen and stored at -70 °C. The remaining mice (n = 20) in the experimental group were returned to normoxia on day 21. On days 22, 24, 28 and 35 five mice from each group were again sacrificed and their lungs removed and processed as described above. At each time point, the right ventricle to total heart mass (RV/T) ratio of each mouse was measured to determine the presence of right ventricular hypertrophy (RVH) resulting from chronic hypoxia-induced pulmonary hypertension.
Pulmonary Vascular Immunohistochemistry and Morphometry
Excised lungs were fixed via intratracheal instillation with 4% formalin and maintained at a transmural pressure of 25 cm H 2 O overnight. Lung samples were embedded in paraffin and 5 µm sections were stained with a monoclonal antibody against α-smooth muscle actin (DAKO) with diaminobenzidine (DAB) as the chromogen (43). The extent of vascular remodeling was determined by measuring percent wall thickness defined as [area ext − area int ]/ area ext × 100, where area ext and area int are the area bounded by the external and internal elastic lamina (29) . Fifty-eight arterioles of comparable size were measured in 13 lungs (n = 5 chronic hypoxia, n = 5 normoxia, n = 3 chronic hypoxia with return to normoxia). Statistical significance was determined using the Wilcoxon-MannWhitney rank sum test.
RNA Isolation and cDNA Microarray Hybridization
Whole lungs of experimental and control mice were pooled separately at each of the nine time points. Total RNA was isolated using the Qiagen Rneasy Maxi Kit (Qiagen). RNA integrity was confirmed using the Agilent Bioanalyzer 2100 system (Agilent Technologies). 50 µg of total RNA from experimental and control mice was labeled with Cy5 and Cy3 monoreactive dyes using a modified amino-allyl reverse transcription protocol (Joseph DeRisi, http://www.microarrays.org). Four replications with dye swapping were performed at each time point for a total of 36 microarray labeling experiments. cDNA microarrays were manufactured at Fred Hutchinson Cancer Research Center and consisted of 15,388 murine genes and expressed sequence tags (ESTs) from a cloneset provided by National Institute on Aging (NIA, http://lgsun.grc.nia.nih.gov/cDNA/15k.html) (39) . All clones had been re-sequenced at the NIA with an error rate estimation of less than 2% prior to manufacturing of cDNA microarrays (23) .
We used the latest gene identifiers for this cloneset provided by NIA (February 2004). After overnight hybridization, each array was scanned using a GenePix 4000A dual-laser scanner.
Image analysis was performed using GenePix Pro 4.0 software (Axon Instruments). For each spot, the median background intensity was subtracted from the median spot intensity in order to minimize background noise. Complete details of experiment design, hybridization procedures, and raw microarray data in compliance with Minimum Information About a Microarray Experiment (MIAME) has been deposited at the Gene Expression Omnibus website (http://www.ncbi.nlm.nih.gov/projects/geo/, query GSE 1909).
cDNA Microarray Data Analysis
Cy3 and Cy5 dyes have different fluorescence properties that result in systematic dye bias. We addressed this issue by performing 4 replications at each time point with dye swapping. We then utilized a Lowess global intensity normalization procedure for each microarray experiment (http://www.r-project.org, sma package) (45) . Differential gene expression at each time point was determined using Significance Analysis of Microarrays (SAM, http://wwwstat.stanford.edu/~tibs/SAM) (41) . Missing values were imputed using a K-nearest-neighbor algorithm. Multiple comparisons problem was addressed by choosing a false discovery rate (FDR) of 5%.
Clustering of temporal gene expression data was performed using partitioning around medoids (PAM) algorithm (http://www.r-project.org, cluster package) (24) . This novel method iteratively assigns dataset objects to k representative objects (medoids) such that the total dissimilarity of all objects to their nearest medoid is minimized. PAM is more robust than other partitioning algorithms such as k-means that implicitly assume each cluster has a spherical normal distribution. PAM also uses a graphical display known as the silhouette plot and a corresponding quality index to determine the optimal number of clusters in the dataset.
Quantitative Real Time RT-PCR (qRT-PCR)
qRT-PCR of selected candidate genes was performed using Taqman Gene Expression Assays (Applied Biosystems). For each gene, cDNA was synthesized from 2 µg of total RNA using SuperScript II reverse transcriptase kit (Invitrogen). qRT-PCR was performed in duplicate using the ABI Prism 7700 Sequence Detection System. After performing validation experiments using serial dilutions and the relative standard curve method, we used the comparative C T method (2 -∆∆CT ) to calculate relative gene expression under experimental and control conditions normalized to 18S control (26) .
ELISA Analysis
We undertook an independent set of experiments to assess differential protein expression of one candidate gene, IGFBP3. Forty, adult, male Balb/C mice were placed in a hypobaric chamber and exposed to 0.5 atm pressure for 3 weeks and then returned to sea level pressure for an additional 2 weeks. On days 7, 14, 21, 28 and 35, eight mice were sacrificed and their lungs removed and weighed. Lungs were not pooled. Thirteen mice kept at sea level pressure were sacrificed and used as controls. Harvested lungs were homogenized in 1.0 ml of protease inhibitor cocktail (Roche Diagnostics). The homogenate was then vigorously mixed with a buffer containing 0.5% Triton X-100, 150 mM NaCl, 15 mM Tris, 1mM CaCl 2 , and 1 mM MgCl 2 (pH 7.40) incubated for 30 min at 4°C and then centrifuged at 10,000×g for 20 min.
The supernatants were stored at −70°C. IGFBP3 concentrations for control and hypoxic mice were measured in duplicate using a DuoSet ELISA kit (R&D Research) and according to the manufacturer's instructions using IGFBP3 standard curves. IGFBP3 protein level was normalized to measured lung weight for each animal. Student's t-test was used to determine statistical difference in IGFBP3 levels between control and hypoxic mice.
Gene Annotation
Gene annotation of all 15,388 genes/ESTs present on cDNA microarrays was obtained by linking them to the Gene Ontology database (GO, http://www.geneontology.org) using Gene MicroArray Pathway Profiler software (GenMAPP 2.0, http://www.genmapp.org). Next, we used MAPPFinder (an ancillary program in GenMAPP) to assess whether specific molecular pathways were over-represented among the differentially expressed genes and within specific gene clusters (10) . We confirmed the results of our gene annotation approach using another program, Expression Analysis Systematic Explorer (EASE, http://david.niaid.nih.gov/david/ease.htm) (18). Although EASE, like GenMAPP, links microarray expression data to their GO annotation and identifies abundantly represented molecular pathways, it uses a different statistical approach to test for significance.
Results
Progression and Regression of Pulmonary Hypertension and RVH
During 21 days of exposure to hypobaric hypoxia, mice developed pulmonary hypertension and RVH as evidenced by progressive increase in their right ventricle to total heart mass ratios (RV/T) compared to control mice ( Figure 2 ) (2). Pulmonary hypertension regressed after returning hypoxic mice to normoxia resulting in the resolution of RVH.
Development of Vascular Remodeling Due to Chronic Hypoxic Pulmonary Hypertension
Pulmonary vascular morphometry based on medial wall thickness of immunostained arterioles was performed on mice exposed to 21 days of hypoxia (n = 5), mice exposed to 21 days of hypoxia and then returned to normoxia for 14 days (n = 3), and on control mice (n = 5). There was a significant increase in medial thickness of mice exposed to hypobaric hypoxia compared with controls (36.3% ± 1.4% vs. 32.5% ± 2.3%, mean ± SE, p = 0.05) consistent with vascular remodeling ( Figure 3 ). There was no difference in the medial wall thickness of pulmonary arterioles between chronically hypoxic mice that were returned to normoxia and control mice, implying regression of pulmonary vascular remodeling after return to normoxia (34.1% ± 2.9% vs. 32.5% ± 2.3%, p = NS).
Statistical Analysis of cDNA Microarray Data
After completing image analysis and nonlinear normalization of all 36 microarrays, we had data from over 15,000 genes with 4 replicates per gene during each of nine time points, totaling more than 500,000 gene expression values. Figure 1 outlines our general approach to reduce the size and complexity of the microarray data. Initially, we determined statistically significant gene expression using SAM, choosing a false discovery rate of 5%. We focused our attention to only the genes that met this criterion during at least two time points. This approach reduced our gene list from 15,388 to 1752 genes. Next, we assessed the robustness of our selection criteria by reanalyzing the data at a FDR of 1%. Over 95% of the genes we had identified remained significant at a FDR of 1% during at least one time point. We then verified our results from SAM by determining significant gene expression using a Bayesian approach outlined by Baldi and Long and implemented as Cyber-T (http://visitor.ics.uci.edu/genex/cybert/) (4). After obtaining Bayesian p-values for each gene at each time point, we applied FDR analysis following the method of Benjamini and Hochberg (6) . At FDR of 5%, there was a 98.1% overlap between Bayesian analysis and SAM, independently confirming the robustness of our statistical approach.
We then performed partitioning around medoids (PAM) clustering algorithm on the 1752 significant genes and obtained the dominant temporal expression patterns of this dataset by dividing it into 7 clusters ( Figure 4 ). These clusters revealed distinct temporal patterns of gene expression during progression and regression of pulmonary hypertension and vascular remodeling. Although cluster analysis is a purely statistical classification method, we were able to interpret biological meaning from its results based on our experimental design. Cluster 1 showed genes that are up regulated during development of pulmonary hypertension but not significantly changed after return to normoxia. Expression patterns of several members of this cluster were highly correlated with the pattern of progression and regression of right ventricular hypertrophy, further suggesting an association between gene expression and development of pulmonary hypertension (20) . These genes included a metalloproteinase (MMP2, r = 0.81), a serine protease inhibitor (Wfdc1, r = 0.78), and a growth factor (IGF1, r = 0.71) all of which are examples of processes contributing to vascular remodeling (21) . Cluster 2 identified genes primarily down regulated during progression of pulmonary hypertension. Clusters 3 and 4 depicted genes that are up or down regulated only after return to normoxia and may therefore be important in regression of pulmonary vascular remodeling. Clusters 5 and 6 revealed genes that were differentially expressed during both progression and regression of pulmonary hypertension.
This finding may imply that both processes share many of the same pathways. Cluster 7 is comprised of only 11 genes (by far the smallest cluster) and is dominated by members of the hemoglobin family. In general, these genes are upregulated during the hypoxic phase of the experiment. We believe this cluster simply represents the presence of nucleated RBCs within harvested lungs and will therefore vary from sample to sample. Our clustering approach captured the salient patterns of gene expression in our model. Since our perturbation consisted of 21 days of hypoxia followed by 14 days of normoxia, we expected the dominant gene expression patterns to "pivot" around day 22. This is precisely the pattern we observed in clusters 1-6 that represent 99.3% of the differentially expressed genes. Full gene list for each cluster is available as online supplementary material.
Gene Annotation Analysis and Identification of Significant Molecular Processes
We utilized two independent methods, GenMAPP/MAPPFinder and EASE, to obtain global insights into the pathogenesis of hypoxic pulmonary hypertension by determining significant molecular processes involved in its development and regression. We initially linked our entire microarray dataset consisting of 15,388 genes/ESTs to the Gene Ontology (GO) database using GenMAPP. This allowed us to annotate our gene products based on their molecular functions, biological processes, and cellular components. We then applied MAPPFinder to the subset of 1752 differentially expressed genes to statistically determine the molecular pathways and processes that were most over-represented during progression and regression of pulmonary hypertension. MAPPFinder calculates a z-score and obtains a permutation-based p-value to determine statistical significance. Next, we confirmed our approach by performing a similar but independent analysis using EASE program. EASE uses a variant of the one-tailed Fisher exact probability and the Gaussian hypergeometric probability distribution to determine an "EASE score" which ranks over-represented GO processes. Additionally, EASE performs a permutation analysis to calculate the global false discovery rate (FDR). FDR addresses the multiple comparisons problem that arises when many processes are evaluated simultaneously. Table 1 lists several of the highest scoring GO processes identified by both EASE and MAPPFinder. Cell adhesion was the most statistically over-represented biological process in our subset of 1752 differentially expressed genes.
Although cluster analysis is a statistical classification method, we designed our experiment such that putative biological roles could be inferred for genes within specific clusters.
We used MAPPFinder and EASE to assess whether specific biological processes were assigned to individual clusters of differentially expressed genes. Cluster 1 (Figure 4) showed the temporal profile of genes up regulated during hypoxic pulmonary hypertension. Table 2 
Highly significant molecular processes in this cluster identified by both MAPPFinder and EASE were overwhelmingly represented by ribosomal activity and protein synthesis (Table 3) . Table 4 lists the dominant process in cluster 4, whose members are down regulated only after return to normoxia. Interestingly, gene ontology analysis reveals that cell adhesion is an important process in both cluster 1 and cluster 4, suggesting a reciprocal role for cluster members during progression and regression of pulmonary hypertension respectively. Several other clusters of differentially expressed genes also had dominant biological themes, implying the functional relevance of our clustering approach (see Figure 7 ; data for all clusters are available as online supplement).
qRT-PCR Confirmation of Selected Candidate Genes
qRT-PCR for expression levels of several candidate genes was performed in duplicates at each of the nine time points. Figure 5 compares the temporal expression patterns of four genes, IQGAP1, decorin, IGFBP3, and lactotransferrin using cDNA microarrays and qRT-PCR. Gene expression values from both methods had very similar temporal trends, although those from qRT-PCR tended to have a relatively greater change. This finding suggests that our microarray results may be underestimating the true differential expression of genes, a phenomenon observed by other investigators as well (15, 46). These candidate genes were chosen because they were members of the key biological processes identified through global gene annotation analysis (Tables 1-4), had not been previously shown to play a role in hypoxic pulmonary hypertension, and were differentially expressed by at least 1.5 fold during multiple time points. IQGAP1 is an important regulator of cell adhesion, decorin is an ECM component, and IGFBP3 is a member of the insulin-like growth factor family. Lactotransferrin is crucial in transition metal ion homeostasis but has not been reported to be involved in vascular remodeling.
ELISA Confirmation of IGFBP3 Expression
IGFBP3 protein levels in whole lung homogenates were significantly reduced in mice (n = 8 for each time point) exposed to 7, 14 and 21 days of hypoxia compared to normoxic animals (n = 13) by 38% (p < 0.05), 45% (p < 0.02), and 43% (p < 0.05) respectively. Mice returned to normoxia (for 1 or 2 weeks) after 3 weeks of hypoxia (n = 8 for each time point) had a nonsignificant reduction in IGFBP3 levels (27%, p = NS during both time points) compared to normoxic mice. These results are summarized in Figure 6 .
Discussion
Pulmonary hypertension due to chronic hypoxia is a clinically important disorder, yet many of the molecular pathways involved in its pathogenesis remain unexplored. Since hypoxic pulmonary hypertension is a complex and dynamic process, studying its evolution and resolution over time can provide valuable insights into its pathogenesis. This study is the first report of the temporal expression profiles of thousands of genes during both progression and regression of hypoxic pulmonary hypertension in mice. Hoshikawa et al, have used transcriptional profiling in a comparative investigation of gene expression in C57BL/6 mice and Sprague-Dawley rat lungs exposed to hypoxia (19) . However, the primary purpose of that novel study was to compare differential gene expression in mice versus rats during hypoxia. Additionally, their experiment was limited to two time points (one and three weeks of hypoxia) and did not sample animals during the resolution of hypoxic pulmonary hypertension. Finally, Hoshikawa et al, did not report significant vascular remodeling in mice, possibly because of strain differences between the mice they studied (C57BL/6) and our Balb/C mice that have been reported to undergo pulmonary vascular remodeling under chronic hypoxia (17) .
An innovative feature of our approach was to initially obtain global insights into this disorder by identifying the key biological processes activated during its development and resolution, and then, to search for novel candidate genes and processes within these biological modules. Utilizing transcriptional profiling, we measured differential gene expression during progression and regression of hypoxic pulmonary hypertension and clustered genes into groups based on their temporal expression patterns. By clustering genes with similar temporal profiles into distinct groups, putative biological roles for candidate genes during progression and regression of pulmonary hypertension were determined.
Next, we used global gene annotation analysis to statistically identify highly represented biological processes in our model of hypoxic pulmonary hypertension. Furthermore, we were able to show that distinct biological themes were present within specific gene clusters, validating our methodology of integrating biological function with statistical classification (Figure 7) . We would like to stress that the above analyses were performed in a systematic and unbiased fashion, with no a priori interest in a specific molecular pathway or gene product.
A prominent feature of chronic hypoxic pulmonary hypertension is the development of vascular and ECM remodeling. This process likely involves complex interactions among cell adhesion molecules, ECM constituents, and proteases and their inhibitors. These processes are also among the most statistically significant ones we identified through global gene annotation analysis (Table 1 ). Cluster analysis of temporal patterns of gene expression enabled us to assign several of these biological processes to distinct clusters and thereby integrate statistical classification of genes with their biological function (Tables 2-4 ). For example, many ECM components were upregulated during development of pulmonary hypertension including collagens 1, 3, 4 and 18, matrix metalloproteinase 2, vimentin and tenascin C; these genes were all grouped into cluster 1 ( Figure 4 and Table 2 ). Many of these ECM components have been previously reported to be differentially expressed during hypoxia-induced pulmonary hypertension (40), including Hoshikawa et al's report on tenascin C in mice (19).
However, not all genes involved in ECM remodeling were grouped into cluster 1. This makes intuitive sense since vascular remodeling is a dynamic process resulting from both up and downregulation of many gene products. Cluster 2 depicts genes primarily downregulated during hypoxic pulmonary hypertension. A member of this cluster, decorin, is a small proteoglycan that interacts with a variety of ECM components and regulates cell attachment, migration and proliferation. Decorin prevents smooth muscle cell proliferation in balloon injured arteries by inhibiting TGF-β and platelet derived growth factor signaling, and has been shown to suppress tumor cell-mediated angiogenesis by inhibiting VEGF (16, 32) . Based on these findings, it is being considered as a possible therapeutic target for prevention of vascular injury, angiogenesis-dependent tumor growth and pulmonary fibrosis (16, 32, 36) . Decorin expression is significantly reduced in our model of pulmonary hypertension ( Figure 5 ) suggesting a state of unhindered smooth muscle proliferation and ECM remodeling. Decorin has been shown to be expressed in pulmonary vessels, but has not been previously reported in pulmonary vascular remodeling and may therefore represent a novel target for therapeutic intervention in pulmonary hypertension (13) .
Insulin-like growth factors (IGFs) comprise an important family of molecules regulating cell adhesion, growth, and proliferation. Differentially expressed members of this family in our model include IGF-1 and IGFBP3, which were assigned to clusters 1 and 2 respectively. IGF-1 is a potent stimulator of growth, proliferation and migration in various tissues including smooth muscle cells, but there are only a few in vitro studies investigating its role in pulmonary arterial hypertension and vascular remodeling (3). IGFBP3 can bind to and inhibit the actions of IGF-1, and has additional anti-proliferative and apoptotic properties mediated through TGF-β and VEGF pathways (9) . Although IGFBP3 has not been implicated in pulmonary vascular remodeling, its expression has been shown to be significantly decreased in human atherosclerotic plaques and recent studies have characterized complex interactions between IGFBP3, IGF-1, collagen 1, and matrix metalloproteinases, suggesting a role for these genes in vascular and ECM remodeling (12, 25, 30, 44 ). In our model, IGF-1 expression is upregulated during development of pulmonary hypertension while IGFBP3 expression is significantly downregulated both at the mRNA and protein levels (Figures 5 and 6 ). This finding implies a loss of inhibition of IGF-1 mediated growth and proliferation and suggests a novel mechanism for pulmonary arterial remodeling.
Another member of cluster 1, lactotransferrin, is upregulated during development of pulmonary hypertension and vascular remodeling in our model ( Figure 5 ). Lactotransferrin is an iron binding protein with diverse functions including metal ion homeostasis, iron metabolism, regulation of inflammatory response and protease activity, but has not been previously described in pulmonary hypertension or pulmonary vascular remodeling (8) . Lactotransferrin enhances mobility of fibroblasts and results in collagen gel contractile activity in an in vitro model of ECM remodeling (38) . Interestingly, lactotransferrin has been shown to bind to and dissociate IGFBP3 from IGF-1, implicating it in the regulation of the IGF signaling system (5).
Furthermore, orally administered human lactotransferrin has been recently demonstrated to promote VEGF-induced angiogenesis in rats (34) . If the role of lactotransferrin is confirmed in pulmonary hypertension and vascular remodeling, this endogenous protein may be a potential target for intervention in this disease.
Cell adhesion was the most over-represented biological process in our model of hypoxic pulmonary hypertension (Table 1) . Candidate genes involved in cell adhesion were members of several clusters suggesting complex expression patterns of their gene products. Several of these candidates were downregulated during both progression and regression of pulmonary hypertension and vascular remodeling (cluster 6) including α-catenin and IQGAP1. IQGAP1 is emerging as a key regulator of cell-cell adhesion, cytokinesis and signal integration in various in vitro cell culture models (7). The expression of IQGAP1 is significantly decreased in our animal model of pulmonary hypertension ( Figure 5 ). If we postulate that IQGAP1 plays a novel role in pulmonary vascular remodeling, our findings are in contrast to in vitro studies that show overexpression of IQGAP1 enhances cell migration and motility (27). However, more recent data reveal a more complex role for IQGAP1, whereby suppression of IQGAP1 expression using small interfering RNA promoted cell-cell dissociation and scattering, a process likely to be important for vascular and ECM remodeling (33).
Our study has several limitations. By using gene expression profiling, we have only measured transcriptome levels and our results need to be verified at the protein level. This is an important issue since mRNA and protein levels are not necessarily tightly correlated due to, for example, post-transcriptional modification of gene products. We have confirmed the differential expression of IGFBP3 at the protein level and plan to verify other candidate genes in future studies. Another limitation of our approach is using whole lungs to isolate RNA, precluding our ability to determine the anatomical location of differential gene expression. Although we observed that chronic hypoxia produces only modest vascular remodeling in Balb/C mice, the histopathological changes found in these lungs were limited to the pulmonary arteries and arterioles, suggesting that the vasculature is likely to be a dominant site for differential gene expression. An alternative method would have been to use laser capture microdissection (LCM) to obtain site-specific tissue (11) . However, this method has several limitations including very low RNA yield, RNA degradation during tissue acquisition, and potential sampling bias due to limited tissue availability (28). Although LCM is a promising and improving technique, we believe that the whole organ approach is the most physiologically appropriate model to study pulmonary hypertension and vascular remodeling.
We decided to pool the lungs of hypoxic and control mice separately at each time point before performing microarray replications. Pooling allowed us to assess the total variability of gene expression (i.e., the sum of both technical and biological noise). Pooling has been widely used in microarray studies in mice and humans and may confer advantages for statistical analyses (1, 15, 22, 35) . However, since we cannot account for animal-to-animal differences, our results may be biased due to the presence of an outlier animal. We addressed this problem by using relatively large numbers of mice at each time point (5 experiment and 5 control for a total of 90 mice), thereby reducing the potential contribution of an outlier. Furthermore, by obtaining gene expression profiles during nine time points we were able to focus our attention on genes differentially expressed during at least two time points, further minimizing outlier effects.
A potential drawback of our experiment design is our inability to distinguish genes differentially expressed due to hypoxia from those due solely to pulmonary hypertension.
However, in several clinical conditions (e.g., COPD, sleep apnea, chronic mountain sickness), hypoxia is an important cause of pulmonary hypertension and both conditions coexist; therefore hypoxia-induced chronic pulmonary hypertension is a physiologically relevant animal model (31) .
We are confident in our statistical approach to determine significant differential gene expression. We performed four replications with dye swapping at each time point, addressed the multiple comparisons problem by limiting the false discovery rate to 5% and performed sensitivity analyses to confirm the robustness of our approach. Since all our candidate genes met these criteria during at least two time points, the actual statistical confidence in their differential expression is likely to be much higher. We confirmed differential gene expression for 4 candidates using qRT-PCR and for one candidate at the protein level. We utilized a recently developed clustering method, partitioning around medoids, to classify temporal expression patterns of candidate genes into biologically meaningful clusters. This algorithm has not been previously applied to time-series gene expression data and is a more robust alternative to the kmeans clustering technique.
Transcriptional profiling has been used extensively as a "hypothesis generating" tool, and as a method to classify different disease entities and even predict survival (42). Important clinical and molecular insights have been obtained, for example, by utilizing microarrays to study primary pulmonary hypertension in humans (14). However, a powerful feature of gene expression analysis is its ability to obtain large-scale "snapshots" of entire biological processes.
We have combined transcriptional profiling with rigorous statistical methods and global gene annotation analysis to gain unique insights into a complex physiological process and to identify the key biological modules involved in the development and regression of hypoxic pulmonary hypertension. By clustering genes based on their temporal expression and annotating individual clusters, we were able to integrate statistical classification of genes with distinct biological functions. This novel methodology designates putative roles for thousands of candidate genes in the context of their temporal expression patterns and memberships in specific biological modules. Our systematic and unbiased approach confirmed several molecular pathways and gene products known to be important in hypoxic pulmonary hypertension. Furthermore, we discovered several novel candidates and molecular mechanisms that may play crucial roles in hypoxia-induced pulmonary hypertension and vascular remodeling. The entire database generated by our study has been made publicly available at our website (http://fmrc.pulmcc.washington.edu/microarray.html) and at the Gene Expression Omnibus website (http://www.ncbi.nlm.nih.gov/projects/geo/, query GSE 1909) to allow independent corroboration of our results and facilitate further research into pulmonary hypertension. 
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